Treatment-Resistant Migraine

RESEARCH STUDY CURRENTLY ENROLLING
call 757-591-8100

Treatment-Resistant Migraine

18-75 years old | Males and Females

To assess the safety and effectiveness of an investigational medication (IV infusion) compared to placebo in the prevention of migraine in patients with treatment-resistant migraine.

Eligibility
  • Have a clinical diagnosis of migraine at least 1 year ago and before the age of 50
  • History of at least 4 migraine headache days per month, on average
  • Have previously tried prescribed migraine prevention medications with little or no success
Trial Duration

11 office visits over approximately 8 months

Compensation

May receive anywhere from $50-$550 per completed visit depending on visit requirements.

Apply for this Study & take the first step towards better care for yourself today.

  • Date Format: MM slash DD slash YYYY